UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Voluntary nullifications of drug license tripled in H1
An increasing number of pharmaceutical companies voluntarily canceled the l...
by Lee Hye-seon
|
2019-06-26 14:25
라인
Celltrion denies delay in local license application for HIV drug Temixys
The Ministry of Food and Drug Safety and Celltrion said rumors about the dr...
by Lee Hye-seon
|
2019-06-25 10:56
라인
Anti-cancer Sutene could cause central nervous system abnormality in fetus
Pfizer Korea’s renal cancer treatments Sutene Cap. (ingredient: sunitinib m...
by Lee Hye-seon
|
2019-06-24 11:35
라인
LSK Global PS wins international recognition in clinical data management
LSK Global PS said it has obtained an international certification for clini...
by Lee Hye-seon
|
2019-06-13 14:30
라인
Daewoong joins fray to develop rheumatoid arthritis drug
Daewoong Pharmaceutical said it has begun developing a rheumatoid arthritis...
by Lee Hye-seon
|
2019-06-07 11:29
라인
Regulator faces serious repercussions after Invossa debacle
The Ministry of Food and Drug Safety recently confirmed that Kolon Life Sci...
by Lee Hye-seon
|
2019-05-29 14:50
라인
Invossa poses almost no safety threat: regulator
The Ministry of Food and Drug Safety said there was no significant concern ...
by Lee Hye-seon
|
2019-05-28 16:02
라인
Gore agrees to supply more artificial blood vessels for children
W.L. Gore & Associates, the sole provider of artificial blood vessels for p...
by Lee Hye-seon
|
2019-05-24 12:53
라인
‘Kolon’s extra data insufficient to explain Invossa mislabeling’
The Ministry of Food and Drug Safety said additional material submitted by ...
by Lee Hye-seon
|
2019-05-23 14:51
라인
Regulator inspecting Kolon TissuGene in US this week
A delegation of the Ministry of Food and Drug Safety left for the U.S. on S...
by Lee Hye-seon
|
2019-05-20 14:22
라인
Preventive use of statin lowers cardiovascular mortality by 44% in seniors
Starting hyperlipidemia treatment, even at the age of 75 or later, can lowe...
by Lee Hye-seon
|
2019-05-15 11:54
라인
YUHS to introduce ‘hospital medicine department'
Yonsei University Health System (YUHS) said it would set up a hospital medi...
by Lee Hye-seon
|
2019-05-03 13:23
라인
Yonsei Cancer Center to provide newest heavy ion therapy in 2022
Celebrating its fifth anniversary this year, Yonsei Cancer Center vowed to ...
by Lee Hye-seon
|
2019-05-02 15:43
라인
When will regulator visit Kolon TissueGene for inspection?
The Ministry of Food and Drug Safety is likely to decide in mid-May on when...
by Lee Hye-seon
|
2019-05-02 14:09
라인
Medical device output up 11.8% in 2018
Korea’s medical devices and related materials output surpassed 6 trillion w...
by Lee Hye-seon
|
2019-04-30 11:25
라인
[Reporter’s Notebook]MFDS incapable of reviewing new drugs?
The most shocking news in the biotech industry in the first half was the mi...
by Lee Hye-seon
|
2019-04-29 16:12
라인
Diarrhea drug Smecta banned for children under 2
The drug authorities have banned the use of dioctahedral smectite-containin...
by Lee Hye-seon
|
2019-04-24 15:42
라인
OECD guideline OKs Korean-developed eye irritation test
Eye irritation test developed in Korea has won the approval as the test gui...
by Lee Hye-seon
|
2019-04-22 15:33
라인
Kolon desperate to keep Invossa license amid suspicion of data fabrication
Kolon Life Science might get its sales license of Invossa-K revoked, as the...
by Lee Hye-seon
|
2019-04-18 11:16
라인
Generic drug approvals doubled amid imminent scrap of consigned bioequivalence tests
After the Ministry of Food and Drug Safety announced that it would graduall...
by Lee Hye-seon
|
2019-04-11 16:00
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top